Compare MDLN & TCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLN | TCOM |
|---|---|---|
| Founded | 1966 | 1999 |
| Country | United States | Singapore |
| Employees | 45000 | 41073 |
| Industry | Medical/Dental Instruments | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0B | 33.0B |
| IPO Year | N/A | N/A |
| Metric | MDLN | TCOM |
|---|---|---|
| Price | $45.56 | $51.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 23 | 8 |
| Target Price | $50.48 | ★ $78.75 |
| AVG Volume (30 Days) | ★ 5.7M | 2.1M |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.88 | $15.86 |
| Revenue Next Year | $7.69 | $13.00 |
| P/E Ratio | $658.75 | ★ $9.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.50 | $48.48 |
| 52 Week High | $50.88 | $79.00 |
| Indicator | MDLN | TCOM |
|---|---|---|
| Relative Strength Index (RSI) | 58.63 | 47.14 |
| Support Level | $43.04 | $48.98 |
| Resistance Level | $46.90 | $54.24 |
| Average True Range (ATR) | 1.46 | 1.03 |
| MACD | 0.41 | 0.41 |
| Stochastic Oscillator | 85.75 | 64.33 |
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.